此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety? (VIDEO-U)

2026年8月1日 更新者:Yair Daykan

Use of a Pre-Procedure Educational Video for Urodynamic Testing as a Tool to Reduce Anxiety: A Prospective Randomized Study

The objective of this randomized prospective study is to evaluate whether viewing an educational video before urodynamic testing reduces anxiety among women undergoing evaluation for pelvic floor or urinary symptoms.

The primary research question is: Does viewing a short educational video before urodynamic testing reduce objective and subjective anxiety levels and improve the overall testing experience? Participants scheduled to undergo urodynamic testing as part of routine clinical care will be randomly assigned to either an educational video intervention or standard pre-procedure counseling alone. Participants will complete brief questionnaires, provide saliva samples for cortisol measurement as an objective biomarker of stress, and report anxiety and pain levels before, during, and after urodynamic testing.

研究概览

详细说明

his study examines whether viewing a short educational video before urodynamic testing reduces anxiety, embarrassment, and discomfort, and improves participants' understanding of the procedure. Urodynamic testing evaluates bladder and urethral sphincter function, and many women experience stress before undergoing the examination. Eligible participants are women whose treating physician has recommended urodynamic testing as part of the evaluation of urinary or pelvic floor symptoms. Participation in the study is entirely voluntary.

Following informed consent, participants will meet with a member of the research team, who will explain the purpose of the study and the urodynamic procedure. Participants will then be randomly assigned to either an educational video intervention group or a standard verbal explanation group. Before the procedure, participants will complete brief questionnaires assessing stress level, coping style, and demographic and clinical characteristics. A saliva sample will be collected for cortisol measurement as an objective biomarker of stress, and blood pressure and heart rate will be recorded.

During urodynamic testing, participants will rate anxiety and pain using a numerical rating scale from 1 to 10, and an additional saliva sample will be collected. After completion of the examination, participants will complete a brief questionnaire evaluating the overall experience, including anxiety, embarrassment, and discomfort. The total duration of study-related procedures, including urodynamic testing, is approximately one hour.

No additional medical risks are anticipated beyond those associated with standard urodynamic testing. Some participants may experience minor discomfort when answering personal questions or providing saliva samples. No additional procedural risks are expected. Although individual benefit cannot be guaranteed, participation may improve preparation for urodynamic testing and reduce anxiety or discomfort. The knowledge gained from this study may contribute to improving the care of future patients undergoing urodynamic evaluation.

All study data will be coded and maintained confidentially to protect participant privacy. Access to identifiable information will be limited to the investigators and authorized regulatory authorities, in accordance with applicable regulations. No identifying information will appear in reports or publications. Participation is voluntary, and participants may decline participation or withdraw from the study at any time without affecting current or future medical care.

研究类型

介入性

注册 (估计的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Israel
      • Kfar Saba、Israel、以色列、11125
        • 招聘中
        • Meir Medical Center
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • women 18 years and above, undergoing a urodynamics test

Exclusion Criteria:

  • women under SSRI/SNRI treatment women with a known anxiety disorder women who had a previous urodynamics test

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Study group- video
Participants in the intervention arm will watch a short educational video explaining the purpose, steps, and sensations expected during urodynamic testing. They will then undergo the standard urodynamic procedure. Anxiety will be assessed using questionnaires and saliva cortisol samples before, during, and after the test, along with self-reported pain and discomfort levels.Video before urodynamics; anxiety measured by surveys and cortisol.
A short video explaining the urodynamics test.
无干预:Control group- No video
Participants in the control arm will receive the standard verbal explanation routinely provided before urodynamic testing, without viewing the educational video. They will then undergo the same assessments as the intervention group, including questionnaires, saliva cortisol collection, and self-reported measures of anxiety, pain, and discomfort at the same time points.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Anxiety represented by cortisol levels
大体时间:through study completion, an average of 1 hour
Comparison between levels of salivary cortisol concentrations before and at the end of the urodynamics test, between the two groups. Cortisol level in nmol/L . the higher difference show increase in stress level
through study completion, an average of 1 hour

次要结果测量

结果测量
措施说明
大体时间
Heart rate and subjective questionnaires
大体时间:through study completion, an average of 1 hour
Comparison between levels of heart rate and subjective anxiety level questionnaire scores, before and during the urodynamics test, between the two groups.
through study completion, an average of 1 hour

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年8月1日

初级完成 (估计的)

2027年5月1日

研究完成 (估计的)

2027年5月1日

研究注册日期

首次提交

2025年12月15日

首先提交符合 QC 标准的

2026年7月28日

首次发布 (实际的)

2026年7月31日

研究记录更新

最后更新发布 (实际的)

2026年8月4日

上次提交的符合 QC 标准的更新

2026年8月1日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅